REAL-WORLD, MULTI-SITE, OBSERVATIONAL STUDY OF INFUSION TIME AND TREATMENT SATISFACTION IN RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH INTRAVENOUS GOLIMUMAB (GLM-IV) OR INFLIXIMAB (IFX)

被引：0
|
作者：
Ellis, L. [1 ]
Le, C. [2 ]
McDermott, J. D., Jr. [3 ]
Daniel, S. [4 ]
机构：
[1] Janssen Sci Affairs LLC, Horsham, PA USA
[2] Covance Market Access Serv Inc, San Diego, CA USA
[3] Covance Market Access Serv Inc, Gaithersburg, MD USA
[4] Covance Market Access Serv Inc, Conshohocken, PA USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS48
引用
收藏
页码：A149 / A149
页数：1
相关论文
共 50 条
  • [1] A real-world, multi-site, observational study of infusion time and treatment satisfaction with rheumatoid arthritis treated with intravenous golimumab or infliximab
    Daniel, Shoshana R.
    McDermott, John D., Jr.
    Le, Cathy
    Pierce, Christine A.
    Ziskind, Michael A.
    Ellis, Lorie A.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (07) : 724 - 731
  • [2] Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
    Jeffrey R. Curtis
    Soumya D. Chakravarty
    Shawn Black
    Shelly Kafka
    Stephen Xu
    Wayne Langholff
    Dennis Parenti
    Andrew Greenspan
    Sergio Schwartzman
    Rheumatology and Therapy, 2021, 8 : 1551 - 1563
  • [3] Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
    Curtis, Jeffrey R.
    Chakravarty, Soumya D.
    Black, Shawn
    Kafka, Shelly
    Xu, Stephen
    Langholff, Wayne
    Parenti, Dennis
    Greenspan, Andrew
    Schwartzman, Sergio
    RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1551 - 1563
  • [4] Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
    Bingham, Clifton O.
    Black, Shawn
    Shiff, Natalie J.
    Xu, Stephen
    Langholff, Wayne
    Curtis, Jeffrey R.
    RHEUMATOLOGY AND THERAPY, 2023, 10 (03) : 659 - 678
  • [5] Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
    Clifton O. Bingham
    Shawn Black
    Natalie J. Shiff
    Stephen Xu
    Wayne Langholff
    Jeffrey R. Curtis
    Rheumatology and Therapy, 2023, 10 : 659 - 678
  • [6] Incidence and Determinants of Infection in Rheumatoid Arthritis (RA) Patients (Pts) Treated with Subcutaneous Golimumab (GLM) in Canadian Real-World Practice
    Bessette, Louis
    Rahman, Proton
    Kelsall, John
    Purvis, Jane
    Rampakakis, Emmanouil
    Lehman, Allen J.
    Rachich, Meagan
    Nantel, Francois
    Marrache, A. Marilise
    Asin-Milan, Odalis
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2802 - 2803
  • [7] Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study
    Argoff, Charles
    Herzog, Steven P.
    Smith, Ryan M.
    Kotak, Sameer V.
    Sopina, Liza
    Saltarska, Yvonna
    Soni-Brahmbhatt, Seema
    Khan, Fawad A.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
  • [8] Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab
    Ellis, Lorie A.
    Malangone-Monaco, Elisabetta
    Varker, Helen
    Stetsovsky, Diana
    Kubacki, Maureen
    DeHoratius, Raphael J.
    Kafka, Shelly
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 99 - 109
  • [9] Real-World Utilization of Infliximab (IFX) and Its Biosimilars in Patients (Pts) with Rheumatoid Arthritis (RA) Since the First Biosimilar Approval in the US
    Helfgott, Simon
    Radtchenko, Janna
    Soloman, Nehad
    Huston, Kent Kwas
    Singh, Jasvinder
    Edgerton, Colin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] UNITED STATES RHEUMATOLOGY PRACTICE-BASED REAL-WORLD EVIDENCE OF INFUSION REACTIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INTRAVENOUS GOLIMUMAB OR INFLIXIMAB: IMPACT OF PRIOR BIOLOGIC EXPOSURE AND METHOTREXATE UTILIZATION
    Schwartzman, S.
    Broadwell, A.
    Kivitz, A.
    Black, S.
    Xu, S.
    Langholff, W.
    Kafka, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 990 - 990
12345